AngioDynamics beat on sales and beat on earnings this morning -- sort of. The company reported a smaller-than-expected ...

Q4 2025 Earnings Call Transcript July 15, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.13. Operator: Good morning, and welcome to the ...

A Capital Region manufacturer expects to continue growing its revenue over the next year, though its bottom line could take a ...

Full Year 2025 Results Key Financial Results Revenue: US$292.5m (down 3.8% from FY ...

Detailed price information for Angiodynamics Inc (ANGO-Q) from The Globe and Mail including charting and trades.

Detailed price information for Angiodynamics Inc (ANGO-Q) from The Globe and Mail including charting and trades.

Gain insights into AngioDynamics' Q4 2025 earnings, highlighting 12% revenue growth, international expansion, Med Tech advances, and a strong FY26 outlook.

Medical technology company AngioDynamics Inc is bucking what it calls an "extraordinary" effort by a rival company to recover hundreds of thousands of dollars in legal costs following its win at ...

QUEENSBURY -- Queensbury-based medical device manufacturer AngioDynamics Inc. said Tuesday afternoon it expects to be in its new headquarters building in Latham by early spring. The company ...

COLONIE — Many Capital Region companies are struggling just to stay afloat during the coronavirus pandemic. But AngioDynamics, the Latham-based medical device manufacturer, is transforming ...

The Motley Fool. DATE Tuesday, July 15, 2025 at 8:00 a.m. ET Read More: Earn up to $845 cash back this year just by changing ...

AngioDynamics, Inc. ( NASDAQ: ANGO) Q4 2025 Earnings Conference Call July 15, 2025 8:00 AM ET James C. Clemmer - CEO, President & Director Stephen A. Trowbridge - Executive VP & CFO ...